100
Participants
Start Date
March 31, 2004
Study Completion Date
July 31, 2005
Avastin (bevacizumab)
Tarceva (erlotinib HCl)
NYU School of Medicine, New York
Our Lady of Mercy Medical Center, The Bronx
North Shore University Hospital, Manhasset
University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia
Raleigh Hematology Oncology, Raleigh
Northwestern Carolina Oncology & Hematology, Hickory
Lynn Regional Cancer Center - West, Boca Raton
The Cleveland Clinic, Cleveland
Wayne State University / Harper University Hospital, Detroit
St. Joseph Oncology, Saint Joseph
Ochsner Cancer Institute, New Orleans
UCHSC - Urologic Oncology, Aurora
UCLA School of Medicine, Los Angeles
Kaiser Permanente Medical Group, San Diego
Stanford University Medical Center, Stanford
Bay Area Cancer Research Group, Concord
Bennett Cancer Center, Stamford
Beth Israel Deaconess Medical Center, Boston
The Cancer Center at Hackensack University Medical Center, Hackensack
Lead Sponsor
Genentech, Inc.
INDUSTRY